首页> 外文期刊>Pulmonary Circulation >Human Immunodeficiency Virus-1 Transgene Expression Increases Pulmonary Vascular Resistance and Exacerbates Hypoxia-Induced Pulmonary Hypertension Development:
【24h】

Human Immunodeficiency Virus-1 Transgene Expression Increases Pulmonary Vascular Resistance and Exacerbates Hypoxia-Induced Pulmonary Hypertension Development:

机译:人类免疫缺陷病毒-1基因表达增加肺血管抵抗力,并加剧缺氧诱导的肺动脉高压的发展:

获取原文
           

摘要

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary arterial resistance and vessel remodeling. Patients living with human immunodeficiency virus-1 (HIV-1) have an increased susceptibility to develop severe pulmonary hypertension (PH) irrespective of their CD4+ lymphocyte counts. While the underlying cause of HIV-PAH remains unknown, the interaction of HIV-1 proteins with the vascular endothelium may play a critical role in HIV-PAH development. Hypoxia promotes PH in experimental models and in humans, but the impact of HIV-1 proteins on hypoxia-induced pulmonary vascular dysfunction and PAH has not been examined. Therefore, we hypothesize that the presence of HIV-1 proteins and hypoxia synergistically augment the development of pulmonary vascular dysfunction and PH. We examined the effect of HIV-1 proteins on pulmonary vascular resistance by measuring pressure-volume relationships in isolated lungs from wild-type (WT) and HIV-1 Transgenic (Tg) rats. WT and HIV-1 Tg rats were exposed to 10% O2 for four weeks to induce experimental pulmonary hypertension to assess whether HIV-1 protein expression would impact the development of hypoxia-induced PH. Our results demonstrate that HIV-1 protein expression significantly increased pulmonary vascular resistance (PVR). HIV-1 Tg mice demonstrated exaggerated pulmonary vascular responses to hypoxia as evidenced by greater increases in right ventricular systolic pressures, right ventricular hypertrophy and vessel muscularization when compared to wild-type controls. This enhanced PH was associated with enhanced expression of HIF-1α and PCNA. In addition, in vitro studies reveal that medium from HIV-infected monocyte derived macrophages (MDM) potentiates hypoxia-induced pulmonary artery endothelial proliferation. These results indicate that the presence of HIV-1 proteins likely impact pulmonary vascular resistance and exacerbate hypoxia-induced PH.
机译:肺动脉高压(PAH)是一种进行性疾病,其特征是肺动脉抵抗力增强和血管重塑。患有人类免疫缺陷病毒1(HIV-1)的患者,不管其CD4 +淋巴细胞计数如何,都更容易发展为严重的肺动脉高压(PH)。尽管尚不清楚HIV-PAH的根本原因,但HIV-1蛋白与血管内皮的相互作用可能在HIV-PAH的发展中起关键作用。低氧促进实验模型和人类体内的PH,但尚未检查HIV-1蛋白对低氧诱导的肺血管功能障碍和PAH的影响。因此,我们假设HIV-1蛋白的存在和缺氧协同增效了肺血管功能障碍和PH的发展。我们通过测量来自野生型(WT)和HIV-1转基因(Tg)大鼠的孤立肺中的压力-体积关系,检查了HIV-1蛋白对肺血管阻力的影响。 WT和HIV-1 Tg大鼠暴露于10%的氧气中4周,以诱导实验性肺动脉高压,以评估HIV-1蛋白表达是否会影响缺氧诱导的PH的发展。我们的结果表明,HIV-1蛋白表达显着增加了肺血管阻力(PVR)。与野生型对照组相比,HIV-1 Tg小鼠表现出对低氧的夸大的肺血管反应,这可以通过右室收缩压,右室肥大和血管肌化的增加来证明。这种增强的PH与HIF-1α和PCNA的表达增强有关。此外,体外研究表明,来自HIV感染的单核细胞衍生巨噬细胞(MDM)的培养基可增强缺氧诱导的肺动脉内皮细胞增殖。这些结果表明,HIV-1蛋白的存在可能会影响肺血管阻力并加剧缺氧诱导的PH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号